K v 1.3-induced hyperpolarization is required for efficient Kaposi’s sarcoma–associated herpesvirus lytic replication

Author:

Carden Holli1ORCID,Harper Katherine L.1ORCID,Mottram Timothy J.1ORCID,Manners Oliver1,Allott Katie L.1,Dallas Mark L.2ORCID,Hughes David J.3ORCID,Lippiat Jonathan D.4ORCID,Mankouri Jamel1,Whitehouse Adrian15ORCID

Affiliation:

1. School of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, University of Leeds, LS2 9JT Leeds, UK.

2. School of Pharmacy, University of Reading, RG6 6AP Reading, UK.

3. Biomedical Sciences Research Complex, School of Biology, University of St Andrews, North Haugh, KY16 9ST St Andrews, UK.

4. School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, LS2 9JT Leeds, UK.

5. Department of Biochemistry and Microbiology, Rhodes University, Grahamstown 6140, South Africa.

Abstract

Kaposi’s sarcoma–associated herpesvirus (KSHV) is an oncogenic herpesvirus that is linked directly to the development of Kaposi’s sarcoma. KSHV establishes a latent infection in B cells, which can be reactivated to initiate lytic replication, producing infectious virions. Using pharmacological and genetic silencing approaches, we showed that the voltage-gated K + channel K v 1.3 in B cells enhanced KSHV lytic replication. The KSHV replication and transcription activator (RTA) protein increased the abundance of K v 1.3 and led to enhanced K + channel activity and hyperpolarization of the B cell membrane. Enhanced K v 1.3 activity promoted intracellular Ca 2+ influx, leading to the Ca 2+ -driven nuclear localization of KSHV RTA and host nuclear factor of activated T cells (NFAT) proteins and subsequently increased the expression of NFAT1 target genes. KSHV lytic replication and infectious virion production were inhibited by K v 1.3 blockers or silencing. These findings highlight K v 1.3 as a druggable host factor that is key to the successful completion of KSHV lytic replication.

Publisher

American Association for the Advancement of Science (AAAS)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3